Korea Medical Institute Announces Strategic Partnership with Japan\'s Sakurajyuji Group  On March 20th, Korea Medical Institute (KMI) announced the signing of a strategic partnership agreement with Medimesse, a healthcare facility under Japan's Sakurajyuji Group.This agreement is designed to foster cooperation and development between South Korea and Japan in the healthcare sector. It addresses shared social challenges such as declining birth rates, aging populations, and the rise of chronic diseases due to lifestyle changes.Sakurajyuji Group, a healthcare conglomerate with 3,461 hospital beds across 23 facilities in Japan, is committed to expanding its healthcare operations. Its goal is to improve patient care and community health through medical services, welfare, and preventative healthcare.The partnership aims to address these common social issues by sharing expertise in health screenings and educational programs, exchanging best practices for lifestyle improvements, and promoting overall health. Additionally, the two institutions plan to share the latest medical technologies and research findings and engage in academic exchanges to extend healthy life expectancy.Lee Kwang-bae, Director of Planning and Coordination at KMI, stated, "Through this business agreement, we will share Sakurajyuji Group's healthcare business vision and KMI's global business vision. We are committed to collaboratively advancing the medical industry of both institutions."KMI has been actively expanding internationally, including a strategic business agreement signed with China's Fosun Group in November last year to attract foreign patients and promote Korea's advanced health screening system abroad.This partnership with Sakurajyuji Group will also facilitate the establishment of a cooperative framework among Korea, China, and Japan in the screening sector, striving for early disease detection, prevention, and health promotion through various collaborative projects.Since its founding in 1985, Korea Medical Institute has operated health screening centers in eight locations nationwide, including three in Seoul (Gwanghwamun, Yeouido, Gangnam) and five in other regions (Suwon, Daegu, Busan, Gwangju, Jeju). KMI is dedicated to early disease detection and prevention, promoting public health, and engaging in various social contribution activities. +82-43-713-8999, 8998, 8997 kimakorea@khidi.or.kr

Korea Medical Institute Announces Strategic Partnership with Japan\'s Sakurajyuji Group

KIMA NEWS

Korea Medical Institute Announces Strategic Partnership with Japan's Sakurajyuji Group

April 24,2024

▲(왼쪽부터) 이광배 KMI한국의학연구소 기획조정실장과 쿠라츠 준이치 사쿠라쥬지그룹 이사장이 18일 일본 구마모토에 위치한 ‘Medimesse 검진센터’에서 전략적 업무제휴 협약식을 진행하고 있다. (사진제공=KMI한국의학연구소) 

On March 20th, Korea Medical Institute (KMI) announced the signing of a strategic partnership agreement with Medimesse, a healthcare facility under Japan's Sakurajyuji Group.

This agreement is designed to foster cooperation and development between South Korea and Japan in the healthcare sector. It addresses shared social challenges such as declining birth rates, aging populations, and the rise of chronic diseases due to lifestyle changes.

Sakurajyuji Group, a healthcare conglomerate with 3,461 hospital beds across 23 facilities in Japan, is committed to expanding its healthcare operations. Its goal is to improve patient care and community health through medical services, welfare, and preventative healthcare.

The partnership aims to address these common social issues by sharing expertise in health screenings and educational programs, exchanging best practices for lifestyle improvements, and promoting overall health. Additionally, the two institutions plan to share the latest medical technologies and research findings and engage in academic exchanges to extend healthy life expectancy.

Lee Kwang-bae, Director of Planning and Coordination at KMI, stated, "Through this business agreement, we will share Sakurajyuji Group's healthcare business vision and KMI's global business vision. We are committed to collaboratively advancing the medical industry of both institutions."

KMI has been actively expanding internationally, including a strategic business agreement signed with China's Fosun Group in November last year to attract foreign patients and promote Korea's advanced health screening system abroad.

This partnership with Sakurajyuji Group will also facilitate the establishment of a cooperative framework among Korea, China, and Japan in the screening sector, striving for early disease detection, prevention, and health promotion through various collaborative projects.

Since its founding in 1985, Korea Medical Institute has operated health screening centers in eight locations nationwide, including three in Seoul (Gwanghwamun, Yeouido, Gangnam) and five in other regions (Suwon, Daegu, Busan, Gwangju, Jeju). KMI is dedicated to early disease detection and prevention, promoting public health, and engaging in various social contribution activities.



RELATED Live.

RELATED Doctor

RELATED Members

CONTACT US

Inquiry